title: Multiple effects of a short-term dexamethasone treatment in human skeletal muscle and adipose tissue.
abstract: Glucocorticoids are frequently prescribed drugs with important side-effects such as glucose intolerance and tissue remodeling. The goal was to explore the molecular basis of the response of skeletal muscle and adipose tissue during a short-term dexamethasone treatment to better understand the induction of side-effects of glucocorticoids on these metabolic tissues. Fifteen healthy male subjects were assigned to a 4-day treatment with dexamethasone at 4 mg/day. The primary outcome measures were changes in gene expression profiling of subcutaneous skeletal muscle and adipose tissue. Urinary cortisol, plasma, and metabolic biochemistry were also assessed. In both tissues the prominent observation was a response to stress and increased inflammatory responses. An upregulation of the serum amyloid A was detected in skeletal muscle, adipose tissue, and plasma, whereas circulating levels of C reactive protein, another acute phase protein, decreased along with a worsened insulin sensitivity index. As tissue-specific features, tissue remodeling was shown in skeletal muscle while the adipose tissue exhibited a decreased energy metabolism. Several limitations might be raised due to the small number of subjects investigated: a possible cross talk with the mineralocorticoid receptor, and a single time point may not identify regulations occurring during longitudinal treatment. In line with the known physiological effect of glucocorticoids the early modulation of stress response genes was observed. An unexpected feature was the upregulation of the inflammatory and immune pathways. The identification of novel impact on two glucocorticoid target tissues provides a molecular basis for the design of more specific glucocorticoids devoid of adverse effects.
authors: Inserm, UMR1048, Obesity Research Laboratory, Institut des Maladies Métaboliques et Cardiovasculaires, France. nathalie.viguerie@inserm.fr
authors: Nathalie
authors: N
authors: Viguerie
authors: Flora
authors: F
authors: Picard
authors: Gabby
authors: G
authors: Hul
authors: Balbine
authors: B
authors: Roussel
authors: Pierre
authors: P
authors: Barbe
authors: Jason S
authors: JS
authors: Iacovoni
authors: Carine
authors: C
authors: Valle
authors: Dominique
authors: D
authors: Langin
authors: Wim H M
authors: WH
authors: Saris
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects*; D000328:Adult; D002097:C-Reactive Protein / Q000378:metabolism; D003907:Dexamethasone / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects*; D000685:Serum Amyloid A Protein / Q000235:genetics / Q000378:metabolism
chemical_list: D005938:Glucocorticoids; D000685:Serum Amyloid A Protein; D003907:Dexamethasone; D002097:C-Reactive Protein